Evidence Report: The efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. [electronic resource]
Producer: 20100525Description: 1463-70 p. digitalISSN:- 1526-632X
- Adult
- Cardiotoxins -- adverse effects
- Controlled Clinical Trials as Topic
- Databases, Factual
- Female
- Humans
- Leukemia -- chemically induced
- Male
- Middle Aged
- Mitoxantrone -- adverse effects
- Multiple Sclerosis -- drug therapy
- Multiple Sclerosis, Relapsing-Remitting -- drug therapy
- Systole -- drug effects
- United States
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.